🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 17 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/09/2010 35,51 35,86 34,96 35,12 -0,84% 2,53% 14.353.408
29/09/2010 35,40 35,55 35,17 35,42 -0,35% 1,08% 9.904.858
28/09/2010 35,58 35,76 35,32 35,54 +0,32% 1,23% 13.333.285
27/09/2010 35,70 35,76 35,43 35,43 -0,56% 0,94% 11.592.766
24/09/2010 35,13 35,68 35,05 35,63 +1,86% 1,79% 12.195.052
23/09/2010 34,99 35,30 34,85 34,98 -0,81% 1,28% 11.111.525
22/09/2010 35,03 35,35 34,95 35,27 +0,65% 1,14% 12.992.790
21/09/2010 34,87 35,25 34,70 35,04 +0,49% 1,56% 12.841.039
20/09/2010 34,69 34,96 34,57 34,87 +0,58% 1,13% 11.028.942
17/09/2010 34,83 35,15 34,50 34,67 -0,27% 1,86% 17.186.571
16/09/2010 34,82 34,93 34,54 34,76 -0,22% 1,12% 9.526.006
15/09/2010 34,85 35,18 34,58 34,84 -0,03% 1,72% 12.042.882
14/09/2010 34,45 35,02 34,41 34,85 +0,83% 1,77% 13.468.058
13/09/2010 34,94 34,94 34,35 34,56 -1,17% 1,69% 11.453.173
10/09/2010 34,48 35,03 34,47 34,97 +1,58% 1,63% 11.760.656
09/09/2010 34,34 34,57 34,15 34,43 +0,75% 1,22% 12.119.596
08/09/2010 33,73 34,35 33,72 34,17 +0,99% 1,87% 23.207.750
07/09/2010 34,13 34,13 33,79 33,84 -0,37% 1,01% 26.548.250
03/09/2010 34,09 34,20 33,66 33,96 +0,68% 1,57% 12.049.904
02/09/2010 34,06 34,13 32,94 33,73 -0,76% 3,50% 12.121.482
01/09/2010 33,76 34,12 33,65 33,99 +1,31% 1,38% 13.684.470
31/08/2010 33,07 33,74 32,93 33,55 +1,24% 2,45% 17.379.194
30/08/2010 33,32 33,60 33,13 33,14 -0,77% 1,40% 7.099.466
27/08/2010 33,04 33,50 32,75 33,40 +1,51% 2,28% 10.004.313
26/08/2010 32,98 33,11 32,71 32,90 -0,17% 1,22% 8.903.074
25/08/2010 32,84 33,13 32,46 32,96 +0,29% 2,03% 11.114.878
24/08/2010 33,17 33,21 32,61 32,86 -1,52% 1,81% 11.799.642
23/08/2010 33,11 33,61 32,98 33,37 +1,54% 1,90% 10.455.477
20/08/2010 32,97 33,10 32,68 32,86 -0,78% 1,27% 12.782.875
19/08/2010 33,68 33,72 32,92 33,12 -1,87% 2,38% 12.061.327